Interferon-α therapy for chronic active Epstein-Barr virus infection: Potential effect on the development of T-lymphoproliferative disease

Yasunari Sakai, Shouichi Ohga, Yasuhiko Tonegawa, Hidetoshi Takada, Futoshi Nakao, Hideki Nakayama, Tomonobu Aoki, Shunji Yamamori, Toshiro Hara

研究成果: Contribution to journalArticle査読

26 被引用数 (Scopus)

抄録

Purpose: A patient with aggressive chronic active Epstein-Barr virus (CAEBV) infection is described whose disease activity subsided after interferon (IFN)-α therapy. Patient and Methods: The patient had intermittent fever, cytopenia, liver dysfunction, hepatosplenomegaly, abnormal titers of EBV-associated antibodies, and positive EBV genomes. Results: Despite repeated trials of the antiviral agents prednisolone and γ- globulin, his condition deteriorated. The administration of IFN-α (1 x 105 U/kg subcutaneously 3 times per week) led to a dramatic clinical improvement. During the IFN-α therapy, the rearrangement bands of T-cell antigen receptor genes disappeared assessed by Southern blotting with a decrease in the number of activated T cells, although the EBV-genome remained evident. Conclusions: These observations suggest that IFN-α is useful in managing CAEBV, possibly restraining the clonal development of T-lymphoproliferative disease (LPD) and EBV-associated B-LPD, although it does not eradicate the proliferation of EBV.

本文言語英語
ページ(範囲)342-346
ページ数5
ジャーナルJournal of Pediatric Hematology/Oncology
20
4
DOI
出版ステータス出版済み - 7 1998

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Oncology

フィンガープリント 「Interferon-α therapy for chronic active Epstein-Barr virus infection: Potential effect on the development of T-lymphoproliferative disease」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル